Influenza Vaccine Dose and Dementia Outcomes - Scorecard - MDSpire

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

  • By

  • Kathryn Wighton

  • April 10, 2026

  • 3 min

Share

Clinical Scorecard: Influenza Vaccine Dose and Dementia Outcomes

At a Glance

CategoryDetail
Condition
Key MechanismsPotential protection against influenza infection or unclear immune effects.
Target Population
Care Setting

Key Highlights

  • High-dose influenza vaccine associated with lower risk of incident Alzheimer dementia, but evidence is Class II.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Potential misclassification in claims-based data and residual confounding; consider these in clinical decisions.

        Patient & Prescribing Data

        High-dose vaccination may reduce the risk of developing Alzheimer dementia, but consider potential misclassification.

        Clinical Best Practices

        • Encourage seasonal high-dose influenza vaccination in older adults, monitoring for reverse causality or detection bias.

        Related Resources & Content

        Original Source(s)

        Influenza Vaccine Dose and Dementia Outcomes

        • by Kathryn Wighton

        • April 10, 2026

        Related Content

        FDA Approves At-Home Starting Dose for Lecanemab

        Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

        Admission ECG-derived resting heart rate and in-hospital mortality after acute stroke: a multicenter retrospective cohort study

        Stroke Programs Earn Recognition From 'Get With The Guidelines®'

        Baptist Health Brain & Spine Care Stroke Programs at nine Baptist Health hospitals have earned recognition from the American Heart Association and American Stroke Association.

        • by

        • July 9, 2026

        • 3 min